Tag: cancer
-
Trial to Test AI-Designed Cancer Antibody Therapy
A clinical trial is set to begin evaluating a synthetic antibody treatment for solid tumor cancer designed with machine learning algorithms.
-
Drug Discovery Biotech Inks Partnering Deal, Gains $175M
A biotechnology company discovering protein therapies in fungi is collaborating with drug maker GlaxoSmithKline to find new small molecule drugs.
-
Virtual Trial to Test Digital Cancer Stress Therapies
A home-based clinical trial is set to begin testing digital therapies for relieving anxiety and managing other health challenges among cancer patients.
-
Trial Assessing AI-Aided Blood Test for Early Stage Cancer
A clinical trial is underway enrolling people with and without cancer to evaluate blood samples analyzed with artificial intelligence to detect early-stage cancer.
-
Precision Meds Continue Gaining FDA Approvals
Food and Drug Administration approved 17 new medications in 2021 addressing genetic targets, according to data from a precision medicine advocacy group.
-
New Industry, Academic Studies Arrive at Space Station
Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions.
-
Infographic – Cancer Drugs Main Pharma Money Source
Our infographic this weekend displays revenue sources overall for drug makers, and the leader by a wide margin is cancer drugs.
-
Precision Cancer Genomics Company Adds $23M in Early Funds
Biofidelity says its process simplifies detection of genetic indicators in tumors enabling more precise therapies for cancer patients.
-
Trial Shows Immunotherapy Improves Lung Cancer Survival
Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy.
-
Sanofi Partners in $5.3B Precision Drug Discovery Deal
A company using artificial intelligence to design drugs for personalized treatments is partnering with drug maker Sanofi in a deal valued at $5.3 billion.